Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Arra

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
ACS Nano|August 19, 2017
Enhanced Drug Delivery into Cell Cytosol via Glycoprotein H-Derived Peptide Conjugated NanoemulsionsTeresa Fotticchia, Raffaele Vecchione, Pasqualina Liana Scognamiglio, et al.
Oncotarget|August 24, 2014
The anti-apoptotic BAG3 protein is expressed in lung carcinomas and regulates small cell lung carcinoma (SCLC) tumor growthGennaro Chiappetta, Anna Basile, Antonio Barbieri, et al.
Cell Death & Disease|July 24, 2019
CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cellsCaterina Ieranò, Crescenzo D'Alterio, Simona Giarra, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 30, 2019
Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1Crescenzo D'Alterio, Maria Buoncervello, Caterina Ieranò, et al.
The Journal of Biological Chemistry|April 12, 2012
POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulationRaffaela Pero, Dario Palmieri, Tiziana Angrisano, et al.
The Journal of Clinical Endocrinology and Metabolism|December 14, 2006
The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligandGennaro Chiappetta, Massimo Ammirante, Anna Basile, et al.
Molecular Cancer Therapeutics|December 21, 2013
Cancer-associated CD43 glycoforms as target of immunotherapyFranca Maria Tuccillo, Camillo Palmieri, Giuseppe Fiume, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2010
IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growthMassimo Ammirante, Alessandra Rosati, Claudio Arra, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2010
CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancyFilomena de Nigris, Valeria Crudele, Alfonso Giovane, et al.
Blood|April 6, 2010
In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binderCamillo Palmieri, Cristina Falcone, Enrico Iaccino, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
ACS Nano|August 19, 2017
Enhanced Drug Delivery into Cell Cytosol via Glycoprotein H-Derived Peptide Conjugated NanoemulsionsTeresa Fotticchia, Raffaele Vecchione, Pasqualina Liana Scognamiglio, et al.
Oncotarget|August 24, 2014
The anti-apoptotic BAG3 protein is expressed in lung carcinomas and regulates small cell lung carcinoma (SCLC) tumor growthGennaro Chiappetta, Anna Basile, Antonio Barbieri, et al.
Cell Death & Disease|July 24, 2019
CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cellsCaterina Ieranò, Crescenzo D'Alterio, Simona Giarra, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 30, 2019
Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1Crescenzo D'Alterio, Maria Buoncervello, Caterina Ieranò, et al.
The Journal of Biological Chemistry|April 12, 2012
POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulationRaffaela Pero, Dario Palmieri, Tiziana Angrisano, et al.
The Journal of Clinical Endocrinology and Metabolism|December 14, 2006
The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligandGennaro Chiappetta, Massimo Ammirante, Anna Basile, et al.
Molecular Cancer Therapeutics|December 21, 2013
Cancer-associated CD43 glycoforms as target of immunotherapyFranca Maria Tuccillo, Camillo Palmieri, Giuseppe Fiume, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2010
IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growthMassimo Ammirante, Alessandra Rosati, Claudio Arra, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2010
CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancyFilomena de Nigris, Valeria Crudele, Alfonso Giovane, et al.
Blood|April 6, 2010
In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binderCamillo Palmieri, Cristina Falcone, Enrico Iaccino, et al.
Pageof 15